AM251型
内大麻素系统
内分泌学
内科学
补品(生理学)
下丘脑
促肾上腺皮质激素释放激素
神经科学
大麻素受体
兴奋剂
敌手
化学
生物
受体
医学
作者
Gavin N. Petrie,Georgia Balsevich,Tamás Füzesi,Robert J. Aukema,Wouter P. F. Driever,Mario van der Stelt,Jaideep S. Bains,Matthew N. Hill
摘要
Abstract Background and Purpose Endocannabinoid (eCB) signalling gates many aspects of the stress response, including the hypothalamic–pituitary–adrenal (HPA) axis. The HPA axis is controlled by corticotropin releasing hormone (CRH) producing neurons in the paraventricular nucleus of the hypothalamus (PVN). Disruption of eCB signalling increases drive to the HPA axis, but the mechanisms subserving this process are poorly understood. Experimental Approach Using an array of cellular, endocrine and behavioural readouts associated with activation of CRH neurons in the PVN, we evaluated the contributions of tonic eCB signalling to the generation of a stress response. Key Results The CB1 receptor antagonist/inverse agonist AM251, neutral antagonist NESS243 and NAPE PLD inhibitor LEI401 all uniformly increased Fos in the PVN, unmasked stress‐linked behaviours, such as grooming, and increased circulating CORT, recapitulating the effects of stress. Similar effects were also seen after direct administration of AM251 into the PVN, while optogenetic inhibition of PVN CRH neurons ameliorated stress‐like behavioural changes produced by disruption of eCB signalling. Conclusions and Implications These data indicate that under resting conditions, constitutive eCB signalling restricts activation of the HPA axis through local regulation of CRH neurons in the PVN.
科研通智能强力驱动
Strongly Powered by AbleSci AI